Bubs Receives Permanent FDA Approval for Formula Supplies
The United States Food and Drug Administration (FDA) has granted Bubs Australia permanent authorization to market three products: Bubs Goat, Bubs 365 Day Grass Fed, and Bubs Essential. The company reported that the regulator confirmed the compliance of their formulations, manufacturing processes, and scientific documentation with American standards.
Bubs has identified itself as the only Australian infant milk formula brand with permanent supply approval in the USA. CEO and Managing Director Joe Kwet stated that this decision marks a significant milestone for Bubs, affirming the quality of their products, manufacturing capabilities, and supply chain from farm to finished product.
According to Kwet, the approval lays the groundwork for expanding collaborations with retail chains and increasing brand recognition. Bubs products are already available in over 10,000 stores nationwide.
The company first applied for permanent approval in 2022, during a nationwide infant formula shortage in the USA. The shortage was linked to potential contamination at an Abbott Laboratories facility. The U.S. administration temporarily allowed foreign manufacturers, including Bubs, to supply the market to enhance the availability of infant nutrition.
Following the permanent approval, Bubs announced plans to enter the U.S. market for private-label formulas and other infant nutrition products. Kwet noted that this would require additional regulatory, technical, and commercial procedures. He also described the FDA approval as a strategic asset for the company.
The regulator's decision came weeks after Bubs released its financial results for the 12 months ending June 30. The company's revenue reached 111.9 million Australian dollars, or 80.56 million USD, rising by 9.2% year-on-year. U.S. sales increased by 24% to 65.8 million Australian dollars, or 47.4 million USD. Bubs attributed the growth to demand for premium goat milk-based products, distribution expansion, and securing supplies. However, gross profit declined by 9.4% to 44.5 million Australian dollars, or 32 million USD, due to increased air freight costs, regulatory compliance expenses, and customs tariffs.
